Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3068% below fair value
$4.03+0.02 (+0.50%)
Close on Nov 13, 2026Market cap $196.17MP/E –Yield –
Nu Skin Enterprises total assets
Total assets on the balance sheet at the end of each period.
Nu Skin Enterprises's total assets was $1.09B at Sep 30, 2026. For fiscal 2025 it was $1.41B, down 4.3% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $1.96B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.41B | -4.3% |
| FY2024 | Dec 31, 2024 | $1.47B | -18.8% |
| FY2023 | Dec 31, 2023 | $1.81B | -0.7% |
| FY2022 | Dec 31, 2022 | $1.82B | -4.5% |
| FY2021 | Dec 31, 2021 | $1.91B | -2.6% |
| FY2020 | Dec 31, 2020 | $1.96B | +10.6% |
| FY2019 | Dec 31, 2019 | $1.77B | +4.4% |
| FY2018 | Dec 31, 2018 | $1.69B | +6.6% |
| FY2017 | Dec 31, 2017 | $1.59B | +7.9% |
| FY2016 | Dec 31, 2016 | $1.47B | -2.1% |
| FY2015 | Dec 31, 2015 | $1.51B | -6.7% |
| FY2014 | Dec 31, 2014 | $1.61B | -11.3% |
| FY2013 | Dec 31, 2013 | $1.82B | +61.9% |
| FY2012 | Dec 31, 2012 | $1.12B | +13.5% |
| FY2011 | Dec 31, 2011 | $990.96M | +11.1% |
| FY2010 | Dec 31, 2010 | $892.22M | +19.2% |
| FY2009 | Dec 31, 2009 | $748.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.09B | -23.6% |
| Q2 FY2026 | Jun 30, 2026 | $1.12B | -22.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.38B | -1.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.41B | -4.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.42B | -10.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.44B | -9.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.39B | -20.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.47B | -18.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.58B | -11.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.59B | -16.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.74B | -4.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.81B | -0.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.79B | +1.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.89B | -0.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.82B | -3.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.82B | -4.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.76B | -10.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.90B | -7.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.89B | -3.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.91B | -2.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.97B | +8.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.05B | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.95B | +11.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.96B | +10.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.82B | +4.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.79B | +0.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.75B | -0.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.77B | +4.4% |
| Q3 FY2019 | Sep 30, 2019 | $1.74B | -0.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.79B | +2.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.76B | -1.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.69B | +6.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.75B | +12.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.75B | +15.9% |
| Q1 FY2018 | Mar 31, 2018 | $1.77B | +18.8% |
| Q4 FY2017 | Dec 31, 2017 | $1.59B | +7.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.55B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.51B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.49B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.47B | – |
See a number that looks wrong?